In this study, we describe the protective effect of Vinpocetine with its vasodilatory, anti-inflammatory, and antioxidant effects, and probably via the inhibition of TGF-Beta 1, to protect the heart from maladaptive processes after a cardiac injury like diabetic cardiomyopathy. The gene discussed is TGFB1; the disease is diabetic cardiomyopathy.